Pharmalys Ltd

22/05/2026

At the OneWe Reach Global Conversations & Connections Summit in Accra, Ghana, Pharmalys joined leading voices from across Africa and around the world to help shape the future of health innovation on the continent.

Pharmalys' CEO Marieme Ba took part in important conversations on clinical research, regulatory progress, health equity and African-led innovation, reaffirming a shared vision for a stronger, more self-driven healthcare future across Africa.

Read the full article here

Pharmalys reflects on the OneWe Reach Global Conversations & Connections Summit in Ghana, where CEO Marieme Ba joined African and global leaders advancing clinical research, health innovation and Africa-led healthcare solutions.

21/05/2026

Preventive cholera vaccination campaigns are resuming for the first time in more than three years following a major increase in global vaccine supply. With support from , , and , millions of doses are being deployed in countries like Mozambique, Bangladesh, and the DRC to help protect vulnerable communities amid ongoing outbreaks and climate-related disruptions.

First preventive campaign in over three years launches in Mozambique, with others planned in Bangladesh and the Democratic Republic of the Congo.

20/05/2026

An interesting clip from a BBC Sounds episode highlighting a critical gap in medical research and a strong reliance on male anatomy in clinical trials.
By overlooking the biological complexities of female bodies, including hormonal variations, many drugs are developed without a full understanding of how they will affect women, raising important questions about safety, effectiveness and equity in healthcare.

https://www.bbc.co.uk/news/videos/cx2dl9j76n5o

19/05/2026

Ghana has launched a new Maternal Mental Health Policy aimed at strengthening support for mothers and addressing a major gap in healthcare services. Developed by the Mental Health Authority with support from and national partners, the policy seeks to integrate mental health into routine maternal and child healthcare across the country.

Ghana has taken a significant step to address a long-standing gap in its health system with the official launch of the Maternal Mental Health Policy (MMHP).

18/05/2026

New research from the Women’s Health Initiative reveals a significant link between cardiovascular disease (CVD) risk and fracture incidence in postmenopausal women. Women with higher 10-year predicted CVD risk were more likely to experience major osteoporotic and hip fractures, even after accounting for lifestyle, clinical factors, and competing mortality.
These findings suggest that cardiovascular risk assessments could also inform fracture prevention strategies, highlighting an important intersection between heart and bone health in postmenopausal women.

A higher 10-year predicted CVD risk was associated with higher M*F and hip fracture risk after adjustment for sociodemographic, lifestyle, and clinical factors. CVD risk may have implications for fracture risk assessment in postmenopausal women.

16/05/2026

Sleeping sickness, a deadly parasitic disease spread by tsetse flies, has long been difficult to treat safely, with older therapies involving toxic arsenic injections and complex hospital care. A breakthrough has come with the approval of Acoziborole, a single oral-dose treatment developed by Sanofi and the Drugs for Neglected Diseases Initiative (DNDi). The drug enables “test-and-treat” strategies in remote settings, working for both early and late-stage disease without the need for spinal taps or specialist equipment. Clinical trials in the Democratic Republic of Congo and Guinea showed cure rates of up to 96%.

A single-dose pill for sleeping sickness could simplify treatment and accelerate elimination efforts in Africa.

15/05/2026

At Pharmalys, corporate social responsibility is closely aligned with our mission to advance clinical research and contribute to stronger, more inclusive healthcare systems. With a particular focus on Africa, our initiatives are designed to create sustainable impact while strengthening clinical research ecosystems.

Download our Corporate Social Responsbility brochure here. https://www.pharmalys.com/download-pharmalys-social-responsibility-brochure/

https://www.pharmalys.com/pharmalys-corporate-social-responsibility-sustainable-clinical-research/

Download Pharmalys Social Responsibility Brochure Learn more about our commitments Δ Your first name(Required)Your family name(Required)Your Email(Required) Company NameConsent Check this box to consent to the collection and processing of your personal data.CAPTCHA

09/05/2026

In 2023, meningitis caused around 259,000 deaths and 2.5 million cases worldwide, disproportionately affecting children under five and countries in the African meningitis belt, including Nigeria, Chad and Niger. While vaccination campaigns against Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae and Group B streptococcus have reduced disease burden, gaps in coverage, evolving pathogens like non-polio enteroviruses, and emerging fungal threats continue to drive deaths and disability.

Children under five and countries in the African meningitis belt continue to bear the greatest burden.

08/05/2026

In March, Pharmalys held the first Pharmalys Voice meeting of 2026, bringing colleagues from across the organisation together in an engaging virtual session. For a team of 50 spread across 18 countries, these meetings play a vital role in encouraging open dialogue, collaboration and connection.

Read the full article here

Highlights from the March 2026 Pharmalys Voice meeting, bringing global teams together to share insights, strengthen collaboration and support open dialogue.

06/05/2026

In Senegal, progress in reducing maternal mortality is now being matched by efforts to improve women’s experiences of childbirth. With support from the World Health Organization, the country is implementing respectful maternal care models that prioritise dignity, communication and emotional support alongside clinical safety. By transforming how care is delivered before and during birth, this approach is helping ensure that every woman can experience childbirth not only safely, but with confidence and respect.

Yeumbeul – En moins d’une décennie, Le Sénégal a réduit de plus de 50 % le taux de mortalité maternelle, passant de 392 décès pour 100 000 naissances vivantes en 2015 à 153 en 2023. Derrière ces avancées persistait une réalité plus complexe : dans de nombreuses structures de santé, ...

04/05/2026

Women spend significantly more of their lives in poor health than men (around nine years on average) often during their prime reproductive years. Many of these years are affected by female-specific disorders such as endometriosis, uterine fibroids, and menopause-related conditions, which, while typically benign, have profound personal and societal impacts. Addressing these conditions not only improves women’s quality of life but, according to the McKinsey Health Institute, could boost productivity and reduce healthcare costs by up to US$1 trillion annually.

Women spend 9 years of their lives in poor health, which is 25% more than men.1 For women, these years are not confined to the end of life, but centred earlier in life from menarche up to menopause.1 Over the past decade, substantial s*x differences in disease presentation, progression, and treatmen...